CVS Health raises 2026 forecast on strong cost controls
CVS Health increased its full-year profit outlook to between $7.30 and $7.50 per share after reporting first-quarter earnings that exceeded analyst estimates. The company attributed the growth to improved medical cost management within its Aetna insurance unit and a more profitable drug mix at its pharmacy benefit manager.
Xurve View
洞察:
Xurve View
CVS HEALTH CORP raised its 2026 profit forecast to $7.30–$7.50 per share following improved medical cost controls in its insurance business. The new midpoint exceeds the $7.16 per share average estimate from LSEG data. Tighter cost management in the Aetna unit signals a recovery after several quarterly misses and a leadership change in 2024.
